Mrs Laurie N Ericksen, RPH in Mather, CA - Pharmacist

Mrs Laurie N Ericksen, RPH is a Pharmacist based in Mather, California. Mrs Laurie N Ericksen is licensed to practice in Michigan (license number 5302027604) and her current practice location is 10535 Hospital Way, Mather, California. She can be reached at her office (for appointments etc.) via phone at (916) 366-5321.

NPI number for Mrs Laurie N Ericksen is 1336250240 and her current mailing address is 103 Stroup Ln, Folsom, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1336250240.

Contact Information

	Mrs Laurie N Ericksen, RPH
	10535 Hospital Way, Mather, CA 95655-4200
	(916) 366-5321
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Laurie N Ericksen
Gender	Female
Speciality	Pharmacist
Location	10535 Hospital Way, Mather, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1336250240
Provider Enumeration Date: 08/31/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Mrs Laurie N Ericksen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1336250240	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	5302027604 (Michigan)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Laurie N Ericksen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Laurie N Ericksen, RPH 103 Stroup Ln, Folsom, CA 95630-5149 Ph: (916) 988-7354	Mrs Laurie N Ericksen, RPH 10535 Hospital Way, Mather, CA 95655-4200 Ph: (916) 366-5321

News Archive

New biomarkers in acute cardiac care

In conjunction with clinical assessment and the ECG, simple and rapid blood tests have become the standard for the detection of myocardial infarction. Starting in the year 2000, recommendations by the European Society of Cardiology and other major cardiology societies worldwide have begun to state uniformly that a rise in cardiac troponins - sensitive and specific markers for dying cells in the heart - is a prerequisite for the clinical diagnosis of myocardial infarction.

Nuvo Research's co-operative drug development project with Fraunhofer Institute for developing WF10

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a co-operative drug development project with the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig, Germany for the preclinical and clinical development of WF10 as a potential treatment for Allergic Rhinitis.

Penn researchers to begin Microbion's BisEDT gel Phase 2 trials in post-surgical orthopedic infections

A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, has received a $2.5 million grant from the Congressionally Directed Medical Research Program (CDMRP), provided through the U.S. Department of Defense (DoD), to begin Phase 2 human trials of a study that examines the effective treatment of post-surgical orthopedic infections using Microbion Corporation's topical BisEDT drug.

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing breakthrough treatments for diabetic and other peripheral neuropathies, today announced a collaboration with the Charcot-Marie-Tooth Association, a registered non-profit organization serving the hereditary neuropathy patient community, to validate the role of HDAC6 in multiple forms of Charcot-Marie-Tooth disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor, in animal models.

Vital exhaustion may increase risk of first-time cardiovascular disease by 36%

Fatigue, increased irritability, and feeling demoralized, may raise a healthy man or woman's risk of first-time cardiovascular disease by 36 percent, according to a study led by researchers at Mount Sinai St. Luke's and Mount Sinai Roosevelt hospitals presented on Nov. 17 at the American Heart Association's Scientific Sessions 2014 in Chicago, IL.

Pharmacist in Mather, CA

Alayna Huynh Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way, Mather, CA 95655 Phone: 916-843-7000
Ms. Jane Chan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way, Mather, CA 95655 Phone: 916-366-5321 Fax: 916-843-7370
Christina Y Eng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way # 119, Mather, CA 95655 Phone: 916-843-7000
Ms. Vinny Pham Vo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way, Mather, CA 95655 Phone: 916-843-7000
Heath Ashley Randall, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way, Mather, CA 95655 Phone: 916-276-4734
Mr. Enda Louis Mckenna, R.PH.,MBA,PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way, Mather, CA 95655 Phone: 916-366-5321
Dr. Alan Shoji Yayesaki, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10535 Hospital Way, Inpatient Pharmacy, Mather Hospital, Mather, CA 95655 Phone: 916-843-7060 Fax: 916-843-7349

Mrs Laurie N Ericksen, RPH - Pharmacist in Mather, CA